All In Biotech

Drug Trial Radar · NCT06973187

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Sep 4, 2025

Primary completion

Apr 17, 2028

Study completion Apr 17, 2028

Sponsor

Lead sponsor
BeOne MedicinesBeOne Medicines (BeiGene) (ONC)
Sponsor type
Industry
First posted
May 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of tacabrutideg alone compared with pirtobrutinib in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who had been previously treated with a covalent Bruton tyrosine kinase inhibitor (cBTKi).

Conditions

  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma

Interventions

  • TacabrutidegDrug

    Tacabrutideg will be administered orally

  • PirtobrutinibDrug

    Pirtobrutinib will be administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS) per Independent Review Committee (IRC)Time frame: Up to approximately 3 years

Locations

217 sites in 24 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham Hospital

    Birmingham, Alabama · Recruiting

  • Mayo Clinic Phoenix

    Phoenix, Arizona · Recruiting

  • Kaiser Permanente Southern California

    Irvine, California · Recruiting

  • University of California San Diego (Ucsd) Moores Cancer Center

    La Jolla, California · Recruiting

  • Cancer and Blood Specialty Clinic

    Los Alamitos, California · Recruiting

  • UCLA Department of Medicine Hematologyoncology

    Los Angeles, California · Recruiting

  • Kaiser Permanente Oakland Medical Center

    Oakland, California · Recruiting

  • Stanford Cancer Institute

    Palo Alto, California · Recruiting

  • Kaiser Permanente Roseville Medical Center

    Roseville, California · Recruiting

  • Kaiser Permanente San Francisco Medical Center Oncology

    San Francisco, California · Recruiting

  • Kaiser Permanente Santa Clara Medical Center Oncologyhematology

    Santa Clara, California · Recruiting

  • Kaiser Permanente Northern California

    Vallejo, California · Recruiting

  • Kaiser Permanente Walnut Creek Medical Center

    Walnut Creek, California · Recruiting

  • Christiana Care

    Newark, Delaware · Recruiting

  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia · Recruiting

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • Cancer Specialists of North Florida

    Jacksonville, Florida · Recruiting

  • Mount Sinai Medical Center Braman Comprehensive Cancer Center

    Miami, Florida · Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • Mission Cancer and Blood

    Waukee, Iowa · Recruiting

  • The University of Kansas Cancer Center

    Westwood, Kansas · Recruiting

  • Our Lady of the Lake Hospital

    Baton Rouge, Louisiana · Recruiting

  • Mary Bird Perkins Cancer Center

    Baton Rouge, Louisiana · Recruiting

  • Ochsner Clinic Foundation

    New Orleans, Louisiana · Recruiting

  • Dana Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Recruiting

  • Mayo Clinic Rochester

    Rochester, Minnesota · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Titan Health Partners Llc Dba Astera Cancer Care

    East Brunswick, New Jersey · Recruiting

  • John Theurer Cancer Center Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • Columbia University Medical Center

    New York, New York · Recruiting

  • Weill Cornell Medical College Newyork Presbyterian Hospital

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center Mskcc

    New York, New York · Recruiting

  • University of Rochester

    Rochester, New York · Recruiting

  • University of North Carolina At Chapel Hill

    Chapel Hill, North Carolina · Recruiting

  • Atrium Health Levine Cancer Institute (Lci)

    Charlotte, North Carolina · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina · Recruiting

  • Dayton Physician Network

    Dayton, Ohio · Recruiting

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania · Recruiting

Showing 40 of 217 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.